Literature DB >> 10961926

Transcriptional repression by nuclear receptors: mechanisms and role in disease.

J D Love1, J T Gooch, L Nagy, V K Chatterjee, J W Schwabe.   

Abstract

Co-repressor proteins mediate transcriptional repression by nuclear receptors in the absence of ligand. The identification of a co-repressor-receptor interaction motif, and the finding that co-repressors and co-activators compete for the same site on the receptor, suggests a simple mechanism for the switch from repression to activation upon ligand binding. Defects in this mechanism result in dominant-negative receptors that repress transcription. Such receptors have been implicated in several clinically important diseases, including thyroid hormone resistance and diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961926

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  5 in total

Review 1.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

2.  Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1).

Authors:  Nathalie Billon; Christine Jolicoeur; Yasuhito Tokumoto; Björn Vennström; Martin Raff
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1.

Authors:  Alexander Tinnikov; Kristina Nordström; Peter Thorén; Jenny M Kindblom; Stephen Malin; Björn Rozell; Maria Adams; Odelia Rajanayagam; Sven Pettersson; Claes Ohlsson; Krishna Chatterjee; Björn Vennström
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

4.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

5.  Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.

Authors:  Laura Fozzatti; Jeong Won Park; Li Zhao; Mark C Willingham; Sheue-Yann Cheng
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.